Persistent Systems partners with NVIDIA to speed up drug discovery with AI
The collaboration uses NVIDIA's BioNeMo platform to create virtual drug screening tools that could reduce research timelines from months to days
Bristol Myers Squibb is building the life science industry’s most powerful AI cluster
The pharma giant is deploying a second NVIDIA DGX SuperPOD to give every scientist, not just a few, access to unlimited compute for drug discovery
Eli Lilly brings Oura smart ring to LillyDirect platform
The pharma giant is pushing GLP-1 care beyond the prescription pad, now offering patients free ring sizing kits and biometric tracking tools
Owkin partners with Sanofi to build custom AI agents for drug discovery
Five-year collaboration will create specialized AI assistants using Owkin's K Pro platform to automate pharmaceutical research tasks
Samsung Galaxy Watch8 to help monitor muscle loss in GLP-1 patients
Clinical study with Massachusetts General Hospital will track body composition changes during popular weight-loss treatments
GoodRx launches $15 monthly membership to tackle rising healthcare costs
New subscription program combines free generic drugs, $19 telehealth visits, and discounted dental and vision care
FDA launches real-time clinical trials to speed up drug development
Two proof-of-concept trials now report data directly to regulators as studies progress, with broader pilot program coming this summer
OpenAI launches GPT-Rosalind AI model for life sciences research
New model named after DNA pioneer aims to speed up drug discovery and biochemistry research
Amazon launches nationwide weight-loss program with GLP-1 drugs
The retail giant integrates popular diabetes and weight-loss medications into its healthcare services with transparent pricing and delivery
AI medical scribes get smart glasses upgrade for better patient notes
Vision-enabled AI scribes achieve 98% accuracy compared to 81% for audio-only systems